Sharechat Logo

B&B says stock worthless as bank talks continue

Friday 23rd January 2009

Text too small?
Babcock & Brown, the Australian investment group whose debt-funded acquisition strategy crashed with the credit crunch, said its shares are now worthless as it tries to negotiate a restructuring plan with its banks.

"In the current market environment and based on continuing discussions with the banking syndicate there will be no value for equity holders under the revised business plan and balance sheet restructure of Babcock & Brown International Pty Ltd. and negligible or no value for holders of the company's subordinated notes," it said in a statement to the ASX.

An announcement on the talks with creditors may not come until the week starting February 2, it said. A statement on talks to renegotiate A$150 million of short-term debt had been expected next week. The shares last traded at 32.5 cents before being halted from trading on the ASX on January 18 and suspended on January 12.

The reiteration that its shares have no value comes after the company on January 7 said it had a "substantial" negative asset position and any restructuring was likely to significantly dilute its equity.

By Jonathan Underhill



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors